%0 Journal Article
%T Association of serum omentin levels with microvascular complications of type 2 diabetes mellitus: a systematic review and meta-analysis.
%A Kazemzadeh K
%A Bayani M
%A Khademi R
%A Sadat-Madani SF
%A Habibzadeh A
%A Shirani M
%A Ghadri H
%A Abbasalizadeh M
%A Izadi E
%A Rezaee M
%A Shafiei A
%A Joudaki A
%A Asadigandomani H
%A Deravi N
%A Meybodi SM
%A Bafrani MA
%J J Diabetes Metab Disord
%V 23
%N 1
%D 2024 Jun
%M 38932798
暂无%R 10.1007/s40200-023-01359-2
%X <B>UNASSIGNED: </B>Type 2 diabetes mellitus (T2DM) is a chronic condition associated with various microvascular complications, including neuropathy, retinopathy, and nephropathy. Recent studies have suggested a potential association between serum omentin levels and the risk of developing microvascular complications in patients with T2DM. However, the existing evidence remains inconclusive. Therefore, we conducted a systematic review and meta-analysis to examine the association between serum omentin levels and microvascular complications in T2DM patients.<BR><B>UNASSIGNED: </B>A comprehensive search was conducted in PubMed, Scopus, and Google Scholar databases to retrieve relevant articles published up to May 2023. Observational studies investigating omentin levels association with microvascular complications in T2DM patients were included. Data was extracted and hence analyzed.<BR><B>UNASSIGNED: </B>A total of seven cross-sectional articles met the inclusion criteria, with a total population of 1587 participants. The meta-analysis revealed a significant association between serum omentin levels and microvascular complications in patients with T2DM. Serum omentin levels were lower in patients with microvascular complications than in those without complications (Mean difference, 95% confidence interval: -1.31 [-2.50, -0.13], I2 = 99.62%).<BR><B>UNASSIGNED: </B>This systematic review and meta-analysis provides evidence supporting an association between serum omentin levels and microvascular complications in patients with T2DM. The findings suggest that Omentin may be lower in T2DM patients with microvascular complications. Further research is warranted to elucidate the underlying mechanisms and explore the clinical implications of these findings.<BR><B>UNASSIGNED: </B>The online version contains supplementary material available at 10.1007/s40200-023-01359-2.